Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DIEBOLD NIXDORF, IncDBD · Entity 4421 | SVP, Chief Accounting Officer | February 24, 2026 | March 09, 2026 |
| NEWELL BRANDS INC.NWL · Entity 4339 | Chief Accounting Officer | February 16, 2024 | February 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DIEBOLD NIXDORF, Inc
Report date February 24, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,801 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,801 F1: Number includes Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: Number includes Restricted Stock Units.
NEWELL BRANDS INC.
Report date February 16, 2024 · Filed February 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,101 |
Reported balance
After 2024-02-16 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2024-02-16 · Exercise / conversion · Acquired 2,101 · Balance 2,101 F1: The Company's Compensation and Human Capital Committee certified partial achievement of the pre-established performance goals resulting in the vesting of the Reporting Person's target shares. The terms of the Reporting Person's Performance-Based Restricted Stock Units ("PRSU") provided for the payout of 0% to 200% of the original grant based on the actual achievement of performance metrics related to core sales growth and cumulative free cash flow between January 1, 2021. and December 31, 2023. |
| Common StockSEC Table I · non-derivative | Direct | 1,362 |
Reported balance
After 2024-02-16 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2024-02-16 · Tax withholding · Disposed 739 · Balance 1,362 F2: Withholding of shares to cover taxes on the vesting was calculated based on the Company's closing stock price on February 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 3,885 |
Reported balance
After 2024-02-16 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2024-02-16 · Exercise / conversion · Acquired 2,523 · Balance 3,885 |
| Common StockSEC Table I · non-derivative | Direct | 2,998 |
Reported balance
After 2024-02-16 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2024-02-16 · Tax withholding · Disposed 887 · Balance 2,998 F2: Withholding of shares to cover taxes on the vesting was calculated based on the Company's closing stock price on February 16, 2024. |
| Common StockSEC Table I · non-derivative | Direct | 7,528 |
Reported balance
After 2024-02-17 transaction · row 5
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 5 · 2024-02-17 · Exercise / conversion · Acquired 4,530 · Balance 7,528 |
| Common StockSEC Table I · non-derivative | Direct | 5,936 |
Reported balance
After 2024-02-16 transaction · row 6
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 6 · 2024-02-16 · Tax withholding · Disposed 1,592 · Balance 5,936 F2: Withholding of shares to cover taxes on the vesting was calculated based on the Company's closing stock price on February 16, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-02-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-02-16 · Exercise / conversion · Disposed 2,101 · Balance 0 F3: Each PRSU represents the right to receive, following vesting, between 0% and 200% of one share of the Company's common stock. F4: Each PRSU represents the right to receive, following vesting. between 0% and 200% of one share of the Company's common stock based upon the achievement of pre-established performance metrics related to core sales growth and cumulative free cash flow over a three (3) year period between January 1, 2021, and December 31, 2023, and certification of such performance by the Company's Compensation and Human Capital Committee following the conclusion of the performance period. F5: If and to the extent the relevant performance criteria are not met, the PRSU expires on the third anniversary of the grant date with a payout of 0%. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-02-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-02-16 · Exercise / conversion · Disposed 2,523 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F7: The restricted stock unit vests ratably in one-third increments on the grant date's first, second, and third anniversaries, subject to the Reporting Person's continuous employment with the Company. F8: N/A |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-02-17 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-02-17 · Exercise / conversion · Disposed 4,530 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F7: The restricted stock unit vests ratably in one-third increments on the grant date's first, second, and third anniversaries, subject to the Reporting Person's continuous employment with the Company. F8: N/A |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 21,512 |
Reported balance
After 2024-02-16 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-02-16 · Grant · Acquired 21,512 · Balance 21,512 F6: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F7: The restricted stock unit vests ratably in one-third increments on the grant date's first, second, and third anniversaries, subject to the Reporting Person's continuous employment with the Company. F8: N/A |
Filing footnotes · ownership attribution and instrument terms
F1: The Company's Compensation and Human Capital Committee certified partial achievement of the pre-established performance goals resulting in the vesting of the Reporting Person's target shares. The terms of the Reporting Person's Performance-Based Restricted Stock Units ("PRSU") provided for the payout of 0% to 200% of the original grant based on the actual achievement of performance metrics related to core sales growth and cumulative free cash flow between January 1, 2021. and December 31, 2023.
F2: Withholding of shares to cover taxes on the vesting was calculated based on the Company's closing stock price on February 16, 2024.
F3: Each PRSU represents the right to receive, following vesting, between 0% and 200% of one share of the Company's common stock.
F4: Each PRSU represents the right to receive, following vesting. between 0% and 200% of one share of the Company's common stock based upon the achievement of pre-established performance metrics related to core sales growth and cumulative free cash flow over a three (3) year period between January 1, 2021, and December 31, 2023, and certification of such performance by the Company's Compensation and Human Capital Committee following the conclusion of the performance period.
F5: If and to the extent the relevant performance criteria are not met, the PRSU expires on the third anniversary of the grant date with a payout of 0%.
F6: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F7: The restricted stock unit vests ratably in one-third increments on the grant date's first, second, and third anniversaries, subject to the Reporting Person's continuous employment with the Company.
F8: N/A
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Delphi Technologies PLC
Report date October 01, 2020 · Filed October 06, 2020
Section 16 reporting ended · disclosed 2020-10-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-10-01 transaction · row 1
1 source rowRow 1 · 2020-10-01 · Disposition to issuer · Disposed 9,596 · Balance 0 F1: Reflects the disposition of ordinary shares of the Issuer as contemplated by the Transaction Agreement, dated as of January 28, 2020, as amended (the "Transaction Agreement") between the Issuer and BorgWarner Inc. ("BorgWarner"), pursuant to which BorgWarner acquired the Issuer pursuant to a scheme of arrangement (the "Scheme") under Part 18A of the Companies (Jersey) Law 1991, as amended (the "Transaction"). In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each ordinary share was exchanged for 0.4307 of a newly issued share of BorgWarner common stock, par value $0.01 per share, and cash in lieu of any fractional share of BorgWarner common stock. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-10-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-10-01 · Disposition to issuer · Disposed 13,778 · Balance 0 F2: Reflects the disposition of performance-based restricted share units awards as contemplated by the Transaction Agreement. In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each performance-based restricted share unit award was cancelled and converted on the same terms and conditions (other than performance-based vesting conditions) into an award of time-vesting restricted share units of BorgWarner covering a number of shares of BorgWarner common stock determined in accordance with the formula set forth in the Transaction Agreement (which were calculated based on the target number of ordinary shares of Issuer subject to such performance-based restricted share unit award). |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-10-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-10-01 · Disposition to issuer · Disposed 15,601 · Balance 0 F3: Reflects the disposition of restricted share unit awards of Issuer as contemplated by the Transaction Agreement. In accordance with the terms of the Transaction Agreement, at the effective of the Scheme, each restricted share unit award was cancelled and converted on the same terms and conditions (including applicable vesting conditions) into an award of restricted stock units of BorgWarner covering a number of shares of BorgWarner common stock determined in accordance with the formula set forth in the Transaction Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of ordinary shares of the Issuer as contemplated by the Transaction Agreement, dated as of January 28, 2020, as amended (the "Transaction Agreement") between the Issuer and BorgWarner Inc. ("BorgWarner"), pursuant to which BorgWarner acquired the Issuer pursuant to a scheme of arrangement (the "Scheme") under Part 18A of the Companies (Jersey) Law 1991, as amended (the "Transaction"). In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each ordinary share was exchanged for 0.4307 of a newly issued share of BorgWarner common stock, par value $0.01 per share, and cash in lieu of any fractional share of BorgWarner common stock.
F2: Reflects the disposition of performance-based restricted share units awards as contemplated by the Transaction Agreement. In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each performance-based restricted share unit award was cancelled and converted on the same terms and conditions (other than performance-based vesting conditions) into an award of time-vesting restricted share units of BorgWarner covering a number of shares of BorgWarner common stock determined in accordance with the formula set forth in the Transaction Agreement (which were calculated based on the target number of ordinary shares of Issuer subject to such performance-based restricted share unit award).
F3: Reflects the disposition of restricted share unit awards of Issuer as contemplated by the Transaction Agreement. In accordance with the terms of the Transaction Agreement, at the effective of the Scheme, each restricted share unit award was cancelled and converted on the same terms and conditions (including applicable vesting conditions) into an award of restricted stock units of BorgWarner covering a number of shares of BorgWarner common stock determined in accordance with the formula set forth in the Transaction Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2018 Filed Feb 21, 2018 14:44 UTC | Delphi Technologies PLC DLPH · Entity 146095 | GrantOrdinary Shares | 848 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011846 · doc4.xml · nonDerivative · entry 3 Sesplankis Jeffrey M · CIK 0001719391 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,978 F4 · balance_after: Ordinary shares received upon settlement of performance based awards granted pursuant to an approved employee incentive plan the value and issuance of which was conditioned on the company achieving certain operating and financial performance targets over the 2015 through 2017 fiscal year period. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 14:44 UTC | Delphi Technologies PLC DLPH · Entity 146095 | OtherOrdinary Shares | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011846 · doc4.xml · nonDerivative · entry 2 Sesplankis Jeffrey M · CIK 0001719391 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130 F3 · balance_after: Represents the acquisition of ordinary shares upon the disposition of dividend equivalent rights reported in Table 2. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 14:44 UTC | Delphi Technologies PLC DLPH · Entity 146095 | Tax withholdingOrdinary Shares | 215 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011846 · doc4.xml · nonDerivative · entry 1 Sesplankis Jeffrey M · CIK 0001719391 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,127 F1 · kind: Represents ordinary shares being withheld to pay tax liability incident to the vesting of time-based restricted stock units and settlement of dividend equivalent rights previously granted pursuant to an approved employee incentive plan. F2 · balance_after: Includes Ordinary Shares plus an additional 682 of restricted stock units previously granted pursuant to an approved employee incentive plan, which vest at various points with the passage of time and which earn dividend equivalents until fully vested. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 13:46 UTC | Delphi Technologies PLC DLPH · Entity 146095 | GrantDividend Equivalent Rights · Derivative | 4.461 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010748 · doc4.xml · derivative · entry 1 Sesplankis Jeffrey M · CIK 0001719391 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4.461 Underlying: Ordinary Shares · 4.461 shares Expires not disclosed F1 · derivative.exercise_price: Reflects dividend equivalent rights accrued with respect to outstanding awards of time-vesting restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.exercise_date: Reflects dividend equivalent rights accrued with respect to outstanding awards of time-vesting restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. F1 · derivative.expiration_date: Reflects dividend equivalent rights accrued with respect to outstanding awards of time-vesting restricted stock units. Each dividend equivalent right is the economic equivalent of one ordinary share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.